![David MacNaughtan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David MacNaughtan
Private Equity Investor bei
Canada Pension Plan Investment Board Private Investments
Profil
David MacNaughtan is currently a Senior Principal at Canada Pension Plan Investment Board Private Investments, a Partner at Sagard Holdings ULC, and the Partner & Head of Sagard Royalty Partners at Sagard Healthcare Royalties.
He previously worked as a Director at Isotechnika Pharma, Inc., a Director at Jaguar Health, Inc., and as the Executive VP & Co-Head-Royalty Monetization Fund at DRI Capital, Inc. He also served as the Vice President-Business Development at Paladin Labs, Inc. and as an Investment Manager at Royal Bank Capital Corp.
Mr. MacNaughtan holds an MBA from Rotman School of Management and both undergraduate and graduate degrees from Queen's University.
Aktive Positionen von David MacNaughtan
| Unternehmen | Position | Beginn |
|---|---|---|
Canada Pension Plan Investment Board Private Investments
 Canada Pension Plan Investment Board Private Investments Investment ManagersFinance CPPIB Private Investments invests in middle market companies located across the globe primarily in China, Japan, Korea, India, SE Asia and Australia. The firm focuses on technology, healthcare, industrials and service sectors. It provides financing for buyout, secondaries and growth capital requirements with an investment size of more than CAD 500 million. It acquires minority interest and also makes co-investments. | Private Equity Investor | 11.01.2011 |
Sagard Holdings ULC
 Sagard Holdings ULC Investment ManagersFinance Provides alternative asset management services | Corporate Officer/Principal | 01.12.2018 |
Sagard Healthcare Royalties
 Sagard Healthcare Royalties Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01.01.2019 |
Ehemalige bekannte Positionen von David MacNaughtan
| Unternehmen | Position | Ende |
|---|---|---|
| JAGUAR HEALTH, INC. | Direktor/Vorstandsmitglied | 21.02.2020 |
| PALADIN LABS INC. | Corporate Officer/Principal | 01.09.2002 |
Royal Bank Capital Corp. | Corporate Officer/Principal | 01.08.1999 |
DRI Healthcare
 DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Corporate Officer/Principal | - |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Direktor/Vorstandsmitglied | - |
Ausbildung von David MacNaughtan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
DRI Healthcare
DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Finance |
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceuticals | Health Technology |
Rotman School of Management
 Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canada Pension Plan Investment Board Private Investments
Canada Pension Plan Investment Board Private Investments Investment ManagersFinance CPPIB Private Investments invests in middle market companies located across the globe primarily in China, Japan, Korea, India, SE Asia and Australia. The firm focuses on technology, healthcare, industrials and service sectors. It provides financing for buyout, secondaries and growth capital requirements with an investment size of more than CAD 500 million. It acquires minority interest and also makes co-investments. | Finance |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Royal Bank Capital Corp. | |
Jaguar Health, Inc.
 Jaguar Health, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sagard Holdings ULC
Sagard Holdings ULC Investment ManagersFinance Provides alternative asset management services | Finance |
Sagard Healthcare Royalties
Sagard Healthcare Royalties Investment ManagersFinance Functions as an alternative investment manager | Finance |
